Cervical cancer
Conditions
Interventions
Observation group:None
Sponsors
Chinese Academy of Medical Sciences, Peking Union Medical College Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Patients with pathologically confirmed locally advanced cervical cancer (stages IB3 to IVA) meeting standard treatment criteria. 2.Aged between 18 and 70 years, with good immune function and treatment tolerance, capable of completing all steps of the treatment regimen. 3.Patients who have provided informed consent and are willing to participate in the study.
Exclusion criteria
Exclusion criteria: 1.Patients with a history of other malignant tumors or recent active infections. 2.Patients who have previously received immunotherapy or radiotherapy, or have a history of immunodeficiency disorders. 3.Patients with mental disorders, cognitive impairment, or other conditions that prevent them from understanding or signing the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Survival (OS);Progression-Free Survival (PFS);Objective Response Rate (ORR); | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life (QoL);Treatment-Related Adverse Events; | — |
Countries
China
Contacts
Public ContactLi Lei
Chinese Academy of Medical Sciences, Peking Union Medical College Hospital
Outcome results
None listed